Cardiac resynchronization therapy in New York Heart Association class IV heart failure: It is all about selection

Circulation

Volumn 115, Issue 2, 2007, Pages 161-162

  Tang, W H Wilson ^a   Francis, Gary S ^a,b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HORMONE ANTAGONIST; INOTROPIC AGENT;

CARDIAC RESYNCHRONIZATION THERAPY; CLINICAL TRIAL; COHORT ANALYSIS; DATA ANALYSIS; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE SEVERITY; EDITORIAL; HEART FAILURE; HOSPITALIZATION; HUMAN; MORTALITY; PRIORITY JOURNAL; QUALITY OF LIFE; RISK BENEFIT ANALYSIS; SYMPTOMATOLOGY;

CARDIAC PACING, ARTIFICIAL; CARDIAC SURGICAL PROCEDURES; HEART FAILURE, CONGESTIVE; HUMANS; NEW YORK; SOCIETIES, MEDICAL;

EID: 33846229190     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.106.669879     Document Type: Editorial

References (12)

1. Daubert JC, Leclercq C, Donal E, Mabo P. Cardiac resynchronisation therapy in heart failure: current status. Heart Fail Rev. 2006;11:147-154.
2. Rivero-Ayerza M, Theuns DA, Garcia-Garcia HM, Boersma E, Simoons M, Jordaens LJ. Effects of cardiac resynchronization therapy on overall mortality and mode of death: a meta-analysis of randomized controlled trials. Eur Heart J. 2006;27:2682-2688.
3. Vanderheyden M, Wellens F, Bartunek J, Verstreken S, Walraevens M, Geelen P, De Proft M, Goethals M. Cardiac resynchronization therapy delays heart transplantation in patients with end-stage heart failure and mechanical dyssynchrony. J Heart Lung Transplant. 2006;25:447-453.
4. Lehmann MH, Aaronson KD. CRT-D therapy in heart failure: how much do NYHA class IV patients benefit? J Cardiovasc Electrophysiol. 2006;17:491-494.
5. Cowburn PJ, Patel H, Jolliffe RE, Wald RW, Parker JD. Cardiac resynchronization therapy: an option for inotrope-supported patients with end-stage heart failure? Eur J Heart Fail. 2005;7:215-217.
6. James KB, Militello M, Barbara G, Wilkoff BL. Biventricular pacing for heart failure patients on inotropic support: a review of 38 consecutive cases. Tex Heart Inst J. 2006;33:19-22.
7. Konstantino Y, Iakobishvili Z, Arad O, Ben-Gal T, Kusniec J, Mazur A, Porter A, Strasberg B, Battler A, Hasdai D. Urgent cardiac resynchronization therapy in patients with decompensated chronic heart failure receiving inotropic therapy: a case series. Cardiology. 2006;106:59-62.
8. Strickberger SA, Conti J, Daoud EG, Havranek E, Mehra MR, Pina IL, Young J. Patient selection for cardiac resynchronization therapy: from the Council on Clinical Cardiology Subcommittee on Electrocardiography and Arrhythmias and the Quality of Care and Outcomes Research Interdisciplinary Working Group, in collaboration with the Heart Rhythm Society. Circulation. 2005;111:2146-2150.
9. Lindenfeld J, Feldman AM, Saxon L, Boehmer J, Carson P, Ghali JK, Anand I, Singh S, Steinberg JS, Jaski B, DeMarco T, Mann D, Yong P, Galle E, Ecklund F, Bristow M. Effects of cardiac resynchronization therapy with or without a defibrillator on survival and hospitalizations in patients with New York Heart Association class IV heart failure. Circulation. 2007;115:204-212.
10. Hauptman PJ, Masoudi FA, Weintraub WS, Pina I, Jones PG, Spertus JA. Variability in the clinical status of patients with advanced heart failure. J Card Fail. 2004;10:397-402.
11. Desai AD, Burke MC, Hong TE, Kim S, Salem Y, Yong PG, Knight BP. Predictors of appropriate defibrillator therapy among patients with an implantable defibrillator that delivers cardiac resynchronization therapy. J Cardiovasc Electrophysiol. 2006;17:486-490.
12. Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, Tavazzi L. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med. 2005;352:1539-1549.